1. Adema, G.J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y., Nooyen, P., McClanahan, T., Bacon, K.B. & Figdor, C.G. (1997) A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature, 387, 713-717.
2. Agarwal, M., He, C., Siddiqui, J., Wei, J.T. & Macoska, J.A. (2013) CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer. Prostate, 73, 573-581.
3. Balk, S.P., Ko, Y.J. & Bubley, G.J. (2003) Biology of prostate-specific antigen. J. Clin. Oncol., 21, 383-391.
4. Bellinghausen, I., Reuter, S., Martin, H., Maxeiner, J., Luxemburger, U., Tureci, O., Grabbe, S., Taube, C. & Saloga, J. (2012) Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity. J. Allergy Clin. Immunol., 130, 1384-1393.
5. Bouazza, B., Kratassiouk, G., Gjata, B., Perie, S., Lacau St. Guily, J., Butler-Browne, G.S. & Svinartchouk, F. (2009) Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: a pilot study. Neuromuscul. Disord., 19, 199-206.